MELT — Melt Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Melt Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -4.54 | -6.65 |
| Depreciation | ||
| Non-Cash Items | 0.402 | 1.17 |
| Unusual Items | ||
| Other Non-Cash Items | ||
| Changes in Working Capital | -0.356 | 1.26 |
| Change in Prepaid Expenses | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -4.49 | -4.23 |
| Other Investing Cash Flow Items | 0 | 0 |
| Other Investing Cash Flow | ||
| Cash from Investing Activities | 0 | 0 |
| Financing Cash Flow Items | 0 | 12.6 |
| Other Financing Cash Flow | ||
| Cash from Financing Activities | 0 | 12.6 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -4.49 | 8.33 |